Evidence map›Paper›PMID 23118538›Full record

ArticleInternational journal of nanomedicine2012

Enhancement of the dissolution rate and bioavailability of fenofibrate by a melt-adsorption method using supercritical carbon dioxide.

Kwang-Ho Cha, Kyung-Jin Cho, Min-Soo Kim, Jeong-Soo Kim, Hee Jun Park, Junsung Park, Wonkyung Cho, Jeong-Sook Park, Sung-Joo Hwang

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Kwang-Ho ChaYonsei Institute of Pharmaceutical Sciences, Incheon, Republic of Korea.
Kyung-Jin Cho
Min-Soo Kim
Jeong-Soo Kim
Hee Jun Park
Junsung Park
Wonkyung Cho
Jeong-Sook Park
Sung-Joo Hwang
Chungnam National University · KRYonsei University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe aim of this study was to enhance the bioavailability of fenofibrate, a poorly water-soluble drug, using a melt-adsorption method with supercritical CO(2).

methodsFenofibrate was loaded onto Neusilin(®) UFL2 at different weight ratios of fenofibrate to Neusilin UFL2 by melt-adsorption using supercritical CO(2). For comparison, fenofibrate-loaded Neusilin UFL2 was prepared by solvent evaporation and hot melt-adsorption methods. The fenofibrate formulations prepared were characterized by differential scanning calorimetry, powder x-ray diffractometry, specific surface area, pore size distribution, scanning electron microscopy, and energy-dispersive x-ray spectrometry. In vitro dissolution and in vivo bioavailability were also investigated.

resultsFenofibrate was distributed into the pores of Neusilin UFL2 and showed reduced crystal formation following adsorption. Supercritical CO(2) facilitated the introduction of fenofibrate into the pores of Neusilin UFL2. Compared with raw fenofibrate, fenofibrate from the prepared powders showed a significantly increased dissolution rate and better bioavailability. In particular, the area under the drug concentration-time curve and maximal serum concentration of the powders prepared using supercritical CO(2) were 4.62-fold and 4.52-fold greater than the corresponding values for raw fenofibrate.

conclusionThe results of this study highlight the usefulness of the melt-adsorption method using supercritical CO(2) for improving the bioavailability of fenofibrate.

Indexed as

AdsorptionAluminum CompoundsAluminum SilicatesAnimalsBiological AvailabilityCarbon DioxideChromatography, Supercritical FluidDrug CompoundingFenofibrateHot TemperatureHypolipidemic AgentsMagnesiumMagnesium CompoundsMaleMaterials TestingMetabolic Clearance RateAluminum Compoundsaluminum magnesium silicateAluminum SilicatesCarbon DioxideFenofibrateHypolipidemic AgentsMagnesiumMagnesium CompoundsNanocapsulesSilicatesbioavailabilityfenofibratemelt adsorptionsupercritical CO2

Identifiers

PMID23118538
PMCPMC3484728
OpenAlexW2092830561

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.